An A2A adenosine receptor agonist ATL313 reduces inflammation and improves survival in murine sepsis models

摘要

BackgroundThe pathophysiology of sepsis is due in part to early systemic inflammation. Here we describe molecular and cellular responses, as well as survival, in A2A adenosine receptor (AR) agonist treated and untreated animals during experimental sepsis.